Microfluidics for COVID-19: From Current Work to Future Perspective
Biosensors · 2023
DOI: 10.3390/bios13020163 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, 2023. Verfasst von Qi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410017, China. Hauptthemen laut MEDLINE: COVID-19, Microfluidic Analytical Techniques. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project of Hunan Science and Technology, Independent Exploration and Innovation 830 Program for Graduate Students of Central South University.
Abstract (Originalsprache)
Spread of coronavirus disease 2019 (COVID-19) has significantly impacted the public health and economic sectors. It is urgently necessary to develop rapid, convenient, and cost-effective point-of-care testing (POCT) technologies for the early diagnosis and control of the plague’s transmission. Developing POCT methods and related devices is critical for achieving point-of-care diagnosis. With the advantages of miniaturization, high throughput, small sample requirements, and low actual consumption, microfluidics is an essential technology for the development of POCT devices. In this review, according to the different driving forces of the fluid, we introduce the common POCT devices based on microfluidic technology on the market, including paper-based microfluidic, centrifugal microfluidic, optical fluid, and digital microfluidic platforms. Furthermore, various microfluidic-based assays for diagnosing COVID-19 are summarized, including immunoassays, such as ELISA, and molecular assays, such as PCR. Finally, the challenges of and future perspectives on microfluidic device design and development are presented. The ultimate goals of this paper are to provide new insights and directions for the development of microfluidic diagnostics while expecting to contribute to the control of COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410017, China.
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410017, China.
Förderung
- National Natural Science Foundation of China
- Project of Hunan Science and Technology
- Independent Exploration and Innovation 830 Program for Graduate Students of Central South University
Zitieren
APA
Li, Q., Zhou, X., Wang, Q., Liu, W., & Chen, C. (2023). Microfluidics for COVID-19: From Current Work to Future Perspective. Biosensors. https://doi.org/10.3390/bios13020163
Vancouver
Li Q, Zhou X, Wang Q, Liu W, Chen C. Microfluidics for COVID-19: From Current Work to Future Perspective. Biosensors. 2023. doi:10.3390/bios13020163
BibTeX
@article{Li2023,
author = {Li, Qi and Zhou, Xingchen and Wang, Qian and Liu, Wenfang and Chen, Chuanpin},
title = {Microfluidics for COVID-19: From Current Work to Future Perspective},
journal = {Biosensors},
year = {2023},
doi = {10.3390/bios13020163}
}
EUVIMED